Literature DB >> 8635016

Management of vulvar cancer.

H D Homesley1.   

Abstract

BACKGROUND: Current therapy of vulvar malignancies is reviewed with emphasis on screening, etiology, diagnosis, staging, and treatment of preinvasive and invasive cancer.
METHODS: Screening procedures, etiologic possibilities, diagnostic techniques, staging implications, and treatment approaches are discussed in detail.
RESULTS: All malignancies of the vulva should be detected at an early stage, when they are most amenable to curative therapy. Regular examination of all women and increased efforts to educate patients should in time reduce patient and physician delay in diagnosis. The cause of the disease remains unclear, because the precursor state has not been defined accurately. The impetus to perform more conservative surgery has been accompanied by the realization of the severe psychosexual sequelae associated with radical vulvectomy. High risk prognostic factors include number of positive groin lymph nodes and diameter of the primary lesion. Diameter of the largest metastasis, intracapsular versus extracapsular nodal tumor location, laterality of spread, and deep groin nodal spread may be predictors of survival.
CONCLUSIONS: The overall incidence of vulvar malignancies will not be changed until the pathophysiology of the disease is better understood. Improved survival will depend on earlier and more accurate diagnosis and treatment, including use of radiation therapy.

Entities:  

Mesh:

Year:  1995        PMID: 8635016     DOI: 10.1002/1097-0142(19951115)76:10+<2159::aid-cncr2820761341>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Drug therapy for gynaecological cancer in older women.

Authors:  R E van Rijswijk; J B Vermorken
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  Groin lymphadenectomy with preservation of femoral fascia: total inguinofemoral node dissection for treatment of vulvar carcinoma.

Authors:  Leonardo Micheletti; Fabrizio Bogliatto; Marco Massobrio
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

3.  Utilization and Outcomes of Sentinel Lymph Node Biopsy for Vulvar Cancer.

Authors:  Stephanie Cham; Ling Chen; William M Burke; June Y Hou; Ana I Tergas; Jim C Hu; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Obstet Gynecol       Date:  2016-10       Impact factor: 7.661

4.  Perineural Invasion Correlates With Common Pathological Variables and Clinical Outcomes of Patients With Squamous Cell Carcinoma of the Vulva Treated With Primary Radical Surgery and Inguinal-femoral Lymphadenectomy.

Authors:  Angiolo Gadducci; Sabina Pistolesi; Stefania Cosio; Chiara Comunale; Antonio Fanucchi; Antonio Giuseppe Naccarato
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

5.  Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States.

Authors:  A M Stroup; L C Harlan; E L Trimble
Journal:  Gynecol Oncol       Date:  2007-12-21       Impact factor: 5.482

Review 6.  Vulvar carcinoma.

Authors:  R L Coleman; J T Santoso
Journal:  Curr Treat Options Oncol       Date:  2000-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.